Klaus Schroppel
Overview
Explore the profile of Klaus Schroppel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
622
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Willmann M, Bezdan D, Zapata L, Susak H, Vogel W, Schroppel K, et al.
J Antimicrob Chemother
. 2015 Jan;
70(5):1322-30.
PMID: 25583750
Objectives: Here we report on a long-term outbreak from 2009 to 2012 with an XDR Pseudomonas aeruginosa on two wards at a university hospital in southern Germany. Methods: Whole-genome sequencing...
2.
Willmann M, Kuebart I, Marschal M, Schroppel K, Vogel W, Flesch I, et al.
BMC Infect Dis
. 2013 Nov;
13:515.
PMID: 24176052
Background: Blood stream infections (BSI) with Pseudomonas aeruginosa lead to poor clinical outcomes. The worldwide emergence and spread of metallo-β-lactamase (MBL) producing, often multidrug-resistant organisms may further aggravate this problem....
3.
Willmann M, Kuebart I, Vogel W, Flesch I, Markert U, Marschal M, et al.
J Infect
. 2013 Jul;
67(5):416-23.
PMID: 23817209
Objectives: The time to positivity (TTP), measured as the time span between the start of incubation and the alert signal from the blood culture device, has been described as useful...
4.
Willmann M, Marschal M, Holzl F, Schroppel K, Autenrieth I, Peter S
Antimicrob Agents Chemother
. 2013 Feb;
57(4):1797-803.
PMID: 23380719
The association between antimicrobial consumption and resistance in nonfermentative Gram-negative bacteria is well-known. Antimicrobial restriction, implemented in clinical routines by antibiotic stewardship programs (ASPs), is considered a means to reduce...
5.
Burger-Kentischer A, Finkelmeier D, Keller P, Bauer J, Eickhoff H, Kleymann G, et al.
Antimicrob Agents Chemother
. 2011 Jul;
55(10):4789-801.
PMID: 21746957
Fungal infections are a serious health problem in clinics, especially in the immune-compromised patient. Disease ranges from widespread superficial infections like vulvovaginal infections to life-threatening systemic candidiasis. Especially for systemic...
6.
Bauer J, Kinast S, Burger-Kentischer A, Finkelmeier D, Kleymann G, Abu Rayyan W, et al.
J Med Chem
. 2011 Jun;
54(19):6993-7.
PMID: 21711055
Novel nontoxic (S)-2-aminoalkylbenzimidazole derivatives were found to be effective against Candida spp. at low micromolar concentrations using high-throughput screening with infected HeLa cells. A collection of analogues defined the chemical...
7.
Potz-Biedermann C, Schwendemann L, Schroppel K, Sonnichsen K, Schmidt D, Schaller M
J Dtsch Dermatol Ges
. 2011 Apr;
9(10):806-8.
PMID: 21501382
An increasing number of patients with the zoonosis tularemia have been reported in the last few years in Europe. Tularemia can be divided into different forms depending on its appearance....
8.
Leinberger D, Grimm V, Rubtsova M, Weile J, Schroppel K, Wichelhaus T, et al.
J Clin Microbiol
. 2009 Dec;
48(2):460-71.
PMID: 20007393
Extended-spectrum beta-lactamases (ESBL) of the TEM, SHV, or CTX-M type confer resistance to beta-lactam antibiotics in gram-negative bacteria. The activity of these enzymes against beta-lactam antibiotics and their resistance against...
9.
Heeg P, Schroppel K
Med Klin (Munich)
. 2009 Jun;
104(6):464-73.
PMID: 19533054
The increasing number of complicated soft-tissue or invasive infections caused by methicillin-resistant Staphylococcus aureus (MRSA) is a frequent reason for elaborate treatment regimens. Unidentified MRSA carriers may be the origin...
10.
Schweizer A, Schroppel K
Methods Mol Biol
. 2008 Dec;
470:141-9.
PMID: 19089382
Invasive fungal infections comprise a group of serious and life-threatening diseases affecting immunocompromised patients. Molecular analysis of fungal virulence involves the deletion of genes that are suspected for contributing to...